SOLV
Solventum Corporation80.59
-1.30-1.59%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
13.98BP/E (TTM)
9.25Basic EPS (TTM)
8.71Dividend Yield
0%Recent Filings
8-K
10-Q
8-K
8-K
New CCO appointment announced
Solventum Corporation appointed Heather Knight as Chief Commercial Officer effective November 10, 2025, to oversee global commercial and R&D operations across its MedSurg, Dental Solutions, and Health Information Systems segments, reporting to CEO Bryan Hanson. This move coincides with Chris Barry's departure as Executive Vice President and Group President of MedSurg on December 31, 2025, after which he receives severance under the company's plan. Knight's 30 years in MedTech, including her recent COO role at Baxter, positions her to drive integrated growth. Leadership shifts like this sharpen focus amid segment demands.
8-K
Upsized $2B note tender results
Solventum upsized its note tender offers to $2 billion on September 8, 2025, after strong early participation exceeded caps. The company will accept $650 million of 5.450% notes due 2027 at $1,021.65 per $1,000, $797 million of 5.400% notes due 2029 at $1,048.41, $458 million of 6.000% notes due 2064 at $1,042.69, and $22 million of 5.900% notes due 2054 at $1,046.10, with prorated allocations. Funded by its recent purification business sale to Thermo Fisher, this refines Solventum's debt profile. Settlement hits September 10.
IPO
Website
Employees
Sector
Industry
AVTR
Avantor, Inc.
11.20-0.08
BSX
Boston Scientific Corporation
92.95+0.76
HOLX
Hologic, Inc.
75.02-0.17
INFU
InfuSystems Holdings, Inc.
9.29+0.05
ISRG
Intuitive Surgical, Inc.
554.58-4.94
NVST
Envista Holdings Corporation
21.90-0.16
OMI
Owens & Minor, Inc.
3.10+0.09
RMD
ResMed Inc.
247.34-5.73
XRAY
DENTSPLY SIRONA Inc.
11.37-0.03
ZIMV
ZimVie Inc.
18.99+0.00